Literature DB >> 77370

Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis.

N K Ganguly, J G Kingham, B Lloyd, R S Lloyd, C P Price, D R Triger, R Wright.   

Abstract

A sensitive technique was used to estimate two acid hydrolases--N-acetyl-beta-glucosaminidase (N.A.G.) and beta-glucuronidase (B.G.)--produced by peripheral-blood monocytes. Enzyme levels were measured after in-vitro incubation of monocytes with or without stimulation by zymosan and endotoxin. Compared with controls, enzyme production and release in inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis were markedly raised. It is suggested that various stimuli, including immunological ones, may be responsible for the release of such enzymes from monocytes and that such release may be a factor in the production of the chronic inflammation seen in these disorders.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 77370     DOI: 10.1016/s0140-6736(78)90917-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  25 in total

Review 1.  Phagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.

Authors:  J G Williams
Journal:  Ann R Coll Surg Engl       Date:  1990-07       Impact factor: 1.891

2.  IL-10 synergizes with IL-4 and IL-13 in inhibiting lysosomal enzyme secretion by human monocytes and lamina propria mononuclear cells from patients with inflammatory bowel disease.

Authors:  N Lügering; T Kucharzik; H Stein; G Winde; A Lügering; A Hasilik; W Domschke; R Stoll
Journal:  Dig Dis Sci       Date:  1998-04       Impact factor: 3.199

3.  Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies.

Authors:  P Bonniere; B Wallaert; A Cortot; X Marchandise; Y Riou; A B Tonnel; J F Colombel; C Voisin; J C Paris
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

4.  Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease.

Authors:  J G Williams; L E Hughes; M B Hallett
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

5.  Location of nitroblue tetrazolium-reducing activity in human colonic mucosa obtained by biopsy.

Authors:  N Oshitani; A Kitano; H Okabe; S Nakamura; T Matsumoto; K Kobayashi
Journal:  Dig Dis Sci       Date:  1993-03       Impact factor: 3.199

6.  Location of superoxide anion generation in human colonic mucosa obtained by biopsy.

Authors:  N Oshitani; A Kitano; H Okabe; S Nakamura; T Matsumoto; K Kobayashi
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

7.  Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice.

Authors:  Eun-Ha Joh; In-Ah Lee; Sang-Jun Han; Sunju Chae; Dong-Hyun Kim
Journal:  Int J Colorectal Dis       Date:  2009-12-03       Impact factor: 2.571

8.  Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis.

Authors:  Jung-Hee Lee; Bomi Lee; Hye-Sung Lee; Eun-Ah Bae; Hoyong Lee; Young-Tae Ahn; Kwang-Sei Lim; Chul-Sung Huh; Dong-Hyun Kim
Journal:  Int J Colorectal Dis       Date:  2008-12-03       Impact factor: 2.571

9.  Monocyte function in cirrhosis.

Authors:  G Holdstock; B Leslie; S Hill; A Tanner; R Wright
Journal:  J Clin Pathol       Date:  1982-09       Impact factor: 3.411

10.  Gene expression and activity of cartilage degrading glycosidases in human rheumatoid arthritis and osteoarthritis synovial fibroblasts.

Authors:  Mária Pásztói; György Nagy; Pál Géher; Tamás Lakatos; Kálmán Tóth; Károly Wellinger; Péter Pócza; Bence György; Marianna C Holub; Agnes Kittel; Krisztina Pálóczy; Mercédesz Mazán; Péter Nyirkos; András Falus; Edit I Buzas
Journal:  Arthritis Res Ther       Date:  2009-05-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.